Stepan: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Oct. 28, 2026, Stepan (NYSE:SCL) reported an 18% increase in adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, a key measure of operational profitability) to $66 million. Volume expansion in specialty chemicals continues to insulate profitability against raw material inflation. Shareholders benefit when a specialty chemical maker captures market share while keeping plant reactors full.

Three things management said stand out.

Stepan expanded organic sales volume by 7% during the quarter despite flat overall chemical market demand. Customer additions in mid-sized tier-two and tier-three accounts offset softer agricultural demand.

Continue reading